Ke Hao, PhD Email Ke Hao
- ASSOCIATE PROFESSOR | Genetics and Genomic Sciences
- Integrative genomics and xQTLs of disease relevant tissue
- Health effect of environmental toxin exposure
- Somatic structure alternation (SV) in cancer genome
- Algorithm in detecting and genotyping germline CNV and CNV-based association studies
Biography and Research Activities:
Dr. Hao is currently an associate professor of the Department of Genetics and Genomic Sciences and a member of Icahn Institute of Data Science and Genomic Technology. Dr. Hao received his ScD degree and postdoc training at Harvard University and has extensive expertise in statistical genetics, computational biology and environmental health. Over the past decade, Dr. Hao has contributed significantly in these areas. He systematically collected large datasets of human tissue samples, and generated molecular trait quantitative loci (xQTLs), including adipose, blood vessel wall, skeleton muscle, lung, liver, brain, placenta, intestine, whole blood, monocyte, macrophage, etc. Further he integrated the xQTLs with large GWAS data to identify genetic basis of human diseases and discover the mechanism: genetic variants → molecular/cellular alternation → disease. Dr. Hao developed ensembleCNV tool, which detects and genotypes germline copy number variants (CNV) on large scale population data (e.g GWAS). EnsembleCNV is the best-performing CNV caller to date, and achieves accuracy and call-rate comparable to SNP genotype, which paves the path for large CNV-based association studies. Dr. Hao also invented Bio3Air, a system consisted of smartphone APP and wearable devices, for long term monitoring of individual-level air pollution exposure. Bio3Air has been applied to human cohorts in multiple funded studies.
The productive research of Dr. Hao in diverse and inter-related field lead to a number of high profile papers in Nature Genetics, Science, Nature Communications, and Nature Neurosciences.
Biostatistics, Genetics, Mathematical and Computational Biology
Multi-Disciplinary Training Area
Genetics and Data Science [GDS]
BS, Tsinghua University
ScD, Harvard University
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Hao during 2019 and/or 2020. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Celebrix Holdings, LLC
- Merck & Co., Inc.
- Tongji University
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.